SE8405954L - Cefalosporinderivat - Google Patents

Cefalosporinderivat

Info

Publication number
SE8405954L
SE8405954L SE8405954A SE8405954A SE8405954L SE 8405954 L SE8405954 L SE 8405954L SE 8405954 A SE8405954 A SE 8405954A SE 8405954 A SE8405954 A SE 8405954A SE 8405954 L SE8405954 L SE 8405954L
Authority
SE
Sweden
Prior art keywords
cephalosporin derivatives
cephalexin hydrochloride
crystalline cephalexin
converts
moisture
Prior art date
Application number
SE8405954A
Other languages
Unknown language ( )
English (en)
Other versions
SE464026B (sv
SE8405954D0 (sv
Inventor
G L Engel
J M Indelicato
H A Rose
L J Mcshane
K S Yang
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE8405954D0 publication Critical patent/SE8405954D0/sv
Publication of SE8405954L publication Critical patent/SE8405954L/sv
Publication of SE464026B publication Critical patent/SE464026B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE8405954A 1983-12-01 1984-11-26 Kristallint cefalexin-hydroklorid-monohydral, farmaceutiska kompositioner daerav, kristallina cefalexin-hydroklorid-alkanolsolvat SE464026B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/556,887 US4600773A (en) 1983-12-01 1983-12-01 Crystalline cephalexin hydrochloride monohydrate

Publications (3)

Publication Number Publication Date
SE8405954D0 SE8405954D0 (sv) 1984-11-26
SE8405954L true SE8405954L (sv) 1985-06-02
SE464026B SE464026B (sv) 1991-02-25

Family

ID=24223233

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8405954A SE464026B (sv) 1983-12-01 1984-11-26 Kristallint cefalexin-hydroklorid-monohydral, farmaceutiska kompositioner daerav, kristallina cefalexin-hydroklorid-alkanolsolvat

Country Status (46)

Country Link
US (1) US4600773A (sv)
EP (1) EP0143658B1 (sv)
JP (1) JPS60132990A (sv)
KR (1) KR870000527B1 (sv)
AT (1) AT390616B (sv)
AU (1) AU566080B2 (sv)
BE (1) BE901142A (sv)
BG (1) BG40966A3 (sv)
BR (1) BR8406037A (sv)
CH (1) CH661732A5 (sv)
CS (1) CS248725B2 (sv)
CY (1) CY1505A (sv)
DD (1) DD229410A5 (sv)
DE (1) DE3443065A1 (sv)
DK (1) DK158354C (sv)
ES (1) ES538019A0 (sv)
FI (1) FI80274C (sv)
FR (1) FR2555990B1 (sv)
GB (1) GB2150566B (sv)
GR (1) GR81043B (sv)
GT (1) GT198400146A (sv)
HK (1) HK92089A (sv)
HU (1) HU192516B (sv)
IE (1) IE57886B1 (sv)
IL (1) IL73639A (sv)
IN (1) IN163078B (sv)
IT (1) IT1177329B (sv)
JO (1) JO1347B1 (sv)
LU (1) LU85650A1 (sv)
MA (1) MA20279A1 (sv)
MX (1) MX159670A (sv)
MY (1) MY102966A (sv)
NL (1) NL8403588A (sv)
NO (1) NO844711L (sv)
NZ (1) NZ210357A (sv)
OA (1) OA07876A (sv)
PH (1) PH20849A (sv)
PL (1) PL146014B1 (sv)
PT (1) PT79553B (sv)
SE (1) SE464026B (sv)
SG (1) SG59789G (sv)
SU (1) SU1251807A3 (sv)
YU (1) YU45680B (sv)
ZA (1) ZA849224B (sv)
ZM (1) ZM6384A1 (sv)
ZW (1) ZW19084A1 (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2555989B1 (fr) * 1983-12-06 1987-02-20 Bristol Myers Sa Monohydrate de chlorocephadroxyle
DE150507T1 (de) * 1983-12-29 1987-02-26 Mochida Pharmaceutical Co., Ltd., Tokio/Tokyo Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutishe praeparate.
JPS60142987A (ja) * 1983-12-29 1985-07-29 Mochida Pharmaceut Co Ltd セフアロスポリン誘導体
US4840945A (en) * 1985-04-01 1989-06-20 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
US4775751A (en) * 1985-06-03 1988-10-04 Eli Lilly & Company Process for cephalexin hydrochloride alcoholates
JPS63132893A (ja) * 1986-11-25 1988-06-04 Mochida Pharmaceut Co Ltd 新規セフアロスポリン誘導体、その製法およびそれらを有効成分とする抗菌剤
US4880798A (en) * 1986-11-25 1989-11-14 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
US5721229A (en) * 1995-12-26 1998-02-24 Veterinary Pharmacy Corporation Soluble forms of cephalosporins and treatment of animals
GB9717629D0 (en) 1997-08-21 1997-10-22 Johnson Matthey Plc Removal of residual organic solvents
AT413282B (de) * 2002-02-01 2006-01-15 Sandoz Ag Kristalline salze der 7-(((5-amino-1,2,4-thiadiazol-3-yl) (fluoromethoxy-imino)acetyl)amino)-3- ((imino-1-piperazinylmethyl)
US20040033262A1 (en) * 2002-08-19 2004-02-19 Orchid Health Care Sustained release pharmaceutical composition of a cephalosporin antibiotic

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507861A (en) * 1966-09-14 1970-04-21 Lilly Co Eli Certain 3-methyl-cephalosporin compounds
US3655656A (en) * 1970-06-04 1972-04-11 Lilly Co Eli Crystalline cephalexin monohydrate
DE2317179C2 (de) * 1973-04-05 1982-11-25 Bristol-Myers Co., 10154 New York, N.Y. Verfahren zur Herstellung der relativ wasserunlöslichen kristallinen Form von Cefalexinmonohydrat
US3985747A (en) * 1974-05-24 1976-10-12 Bristol-Myers Company Crystalline sesquihydrate of 7-[D-α-amino-α-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
JPS50151890A (sv) * 1974-05-30 1975-12-06
CH642850A5 (it) * 1978-10-20 1984-05-15 Ausonia Farma Srl Composizioni farmaceutiche ad attivita antibatterica contro infezioni da germi gram-positivi e gram-negativi.
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device

Also Published As

Publication number Publication date
ZM6384A1 (en) 1985-07-22
IT8423746A0 (it) 1984-11-27
IN163078B (sv) 1988-08-06
AU3589784A (en) 1985-06-06
KR870000527B1 (ko) 1987-03-14
DE3443065A1 (de) 1985-06-20
NL8403588A (nl) 1985-07-01
ES8602011A1 (es) 1985-11-01
ZA849224B (en) 1986-07-30
FR2555990B1 (fr) 1986-12-26
PT79553A (en) 1984-12-01
KR850004765A (ko) 1985-07-27
MY102966A (en) 1993-03-31
LU85650A1 (fr) 1985-07-17
NO844711L (no) 1985-06-03
IE843033L (en) 1985-06-01
JO1347B1 (en) 1986-11-30
DK158354C (da) 1990-10-01
GB2150566B (en) 1987-08-26
DK561284D0 (da) 1984-11-27
DE3443065C2 (sv) 1989-03-23
PL250593A1 (en) 1985-07-30
GB8430073D0 (en) 1985-01-09
YU199684A (en) 1987-02-28
AT390616B (de) 1990-06-11
GT198400146A (es) 1986-05-20
DK561284A (da) 1985-06-02
BR8406037A (pt) 1985-08-27
SE464026B (sv) 1991-02-25
BG40966A3 (en) 1987-03-14
IT1177329B (it) 1987-08-26
FI844631L (fi) 1985-06-02
CH661732A5 (de) 1987-08-14
ATA373284A (de) 1989-11-15
MA20279A1 (fr) 1985-07-01
ZW19084A1 (en) 1985-06-12
PH20849A (en) 1987-05-08
SG59789G (en) 1989-12-29
HK92089A (en) 1989-11-24
IE57886B1 (en) 1993-05-05
IT8423746A1 (it) 1986-05-27
FI844631A0 (fi) 1984-11-26
EP0143658A2 (en) 1985-06-05
DK158354B (da) 1990-05-07
HUT35685A (en) 1985-07-29
CY1505A (en) 1990-08-03
NZ210357A (en) 1988-05-30
PT79553B (en) 1986-12-15
FI80274C (sv) 1990-05-10
JPS60132990A (ja) 1985-07-16
HU192516B (en) 1987-06-29
DD229410A5 (de) 1985-11-06
FR2555990A1 (fr) 1985-06-07
OA07876A (fr) 1986-11-20
SU1251807A3 (ru) 1986-08-15
AU566080B2 (en) 1987-10-08
GR81043B (en) 1985-03-27
SE8405954D0 (sv) 1984-11-26
EP0143658B1 (en) 1989-03-22
FI80274B (fi) 1990-01-31
IL73639A0 (en) 1985-02-28
YU45680B (sh) 1992-07-20
EP0143658A3 (en) 1986-02-12
GB2150566A (en) 1985-07-03
MX159670A (es) 1989-08-02
IL73639A (en) 1988-06-30
CS248725B2 (en) 1987-02-12
JPH0548234B2 (sv) 1993-07-20
US4600773A (en) 1986-07-15
BE901142A (fr) 1985-05-28
ES538019A0 (es) 1985-11-01
PL146014B1 (en) 1988-12-31

Similar Documents

Publication Publication Date Title
ES500792A0 (es) Procedimiento para preparar derivados de cefalosporina
DK321688A (da) Heterocykliske forbindelser
FI944805A (sv) Indolderivat son 5-HT1-liknande agonister
IT8221182A0 (it) Derivati della cefalosporina eprocedimento per la loro preparazione.
DK450784D0 (da) Azolderivater
ES536550A0 (es) Procedimiento para preparar derivados de cefalosporina
SE8405954D0 (sv) Cefalosporinderivat
DK167984A (da) Alkaloidderivater
IT8048605A0 (it) Enzimaticamente l-triptofano procedimento per preparare
NO885166D0 (no) Ergolinderivater.
DE3678453D1 (de) Cephemderivate.
IT8347826A0 (it) Derivati cefalosporinici e procedimento per la loro preparazione
DK285484D0 (da) Beta-lactam-antibiotikum
DE3263145D1 (de) Deazapurine derivatives
ES533624A0 (es) Procedimiento para la preparacion de derivados de tiazolidina
AU5809580A (en) Benzimidazole derivatives
DK480384D0 (da) Cephalosporinderivater samt fremgangsmaader til fremstilling deraf
DK306284D0 (da) Substituerede phenylsulfonylguanidin-derivater
IT1178465B (it) Procedimento per la preparazione di carbapenem derivati
DE3262401D1 (de) Thiazolidine derivatives
DE3170611D1 (de) Antibiotic novel dianemycin derivative
PT87359A (pt) Process for the preparation of pyrrolidine derivatives
ES524424A0 (es) Procedimiento para la obtencion de derivados carbapenem fluoralquilados
IT1175498B (it) Complesso antibiotico antitumorale bbm-1675
DK223484D0 (da) Indolinderivater

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8405954-2

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8405954-2

Format of ref document f/p: F